3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Fertility and pregnancy -

Studies shed light on preserving fertility among cancer patients

Cancer • • Fertility and pregnancyJul 20, 09

Cancer treatment has come a long way, leading to a multitude of therapy options and improved survival rates. These successes, however, have created a challenge for young cancer patients since chemotherapy and radiation treatments that often save lives threaten fertility. Techniques available to safeguard fertility, such as freezing eggs for later embryo development, have poor odds of success, leaving patients with very limited options for the future. But that is beginning to change as researchers improve current techniques, mature human eggs in the laboratory, and discover cellular mechanisms that could help preserve and even restore fertility. Researchers will report on these and other findings at the 42nd annual meeting of the Society for the Study of Reproduction (SSR), July 18 to 22, at the David L. Lawrence Convention Center in Pittsburgh.

Summaries of the findings are as follows:

Growing Egg Cells in the Lab
Researchers at Northwestern University are developing a method they hope will help preserve a woman’s fertility after radiation and chemotherapy treatment. Led by Teresa K. Woodruff, Ph.D., the team has grown undeveloped human eggs to near maturity in laboratory cultures. During a 30-day experiment, they grew human follicles―tiny sacs that contain immature eggs―in the lab until the eggs they contained were nearly mature. According to Dr. Woodruff, this is the first step in developing a new fertility option for young cancer patients.

Making a More Viable Embryo
Cryopreservation, the process of freezing eggs for later fertilization, has played a major role in assisted reproductive technology for the past two decades. Unfortunately, however, eggs rarely survive the freezing and thawing processes required to develop a viable embryo. A mere half of eggs survive and of these, only 20 percent, once fertilized, result in the birth of a baby. According to David Albertini, Ph.D., University of Kansas Medical Center, clinicians may be waiting too long – three hours – after thawing eggs to initiate fertilization with the sperm, a process necessary to create an embryo. When his research team used confocal microscopy to observe what was happening at a chromosomal level, they found that the structures needed to make the embryo’s chromosomes align and divide were in place after only an hour. This indicates a shorter thawing time frame could have greater potential for success.

Restoring Fertility From the Bottom Up
Researchers at Stanford University, led by Renee A. Reijo Pera, Ph.D., have identified several genes involved in the formation of germ cells that give rise to eggs and sperm. These genes, DAZ and DAZL, form the basis of human embryo and germ cell growth and may be a key to understanding human reproductive failure – one of the most common health problems in men and women and a common cause of birth defects. While continued progress in developing germ cells capable of making embryos renders fertility restoration feasible, it also raises significant ethical questions, says Dr. Reijo Pera.

###

The Society for the Study of Reproduction was founded in 1967 to promote the study of reproduction by fostering interdisciplinary communication among scientists through conferences and publications in the organization’s journal, Biology of Reproduction. The SSR president is Asgerally T. Fazleabas, Ph.D., University of Illinois College of Medicine in Chicago. Program committee chair is Patricia Hunt, Ph.D., Washington State University; and chair of the local organizing committee is Tony M. Plant, Ph.D., University of Pittsburgh School of Medicine.

NOTE TO EDITORS: The scientists will discuss their research during a briefing, “Preserving Fertility: Causes and Solutions,” at 11:30 a.m., Monday, July 20, which will be moderated by Patricia Hunt, Ph.D., Washington State University, and 2009 SSR program chair. All briefings take place in room 312 of the David L. Lawrence Convention Center, Pittsburgh. Reporters may participate via telephone conference call by dialing 800-937-0301 (from within the U.S. and Canada). From other countries, call +1 303-248-9679. To be connected to the briefing, enter access code 6489725. The press room hours are 8 a.m. to 5 p.m., Monday, July 20, through Tuesday, July 21, and 8 a.m. to 1 p.m., Wednesday, July 22. Press room staff may be reached during this time at (412) 352-2886. Otherwise, please call UPMC Media Relations at (412) 647-3555.


Contact: Clare Collins
.(JavaScript must be enabled to view this email address)
412-647-3555
University of Pittsburgh Schools of the Health Sciences



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Widespread agricultural contaminant impacts fish reproductive behavior
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site